Alum boosts TH2-type antibody responses to whole-inactivated virus influenza vaccine in mice but does not confer superior protection

Laura Bungener, Felix Geeraedts, Wouter ter Veer, +2

Vaccine

VaccinationCross-protectionVaccine DevelopmentImmunologyVirology +7

Whole inactivated virus influenza vaccine is superior to subunit vaccine in inducing immune responses and secretion of proinflammatory cytokines by DCs

Felix Geeraedts, Laura Bungener, Judith G. Pool, +3

Influenza and Other Respiratory Viruses

Preservation of the Immunogenicity of Dry-powder Influenza H5N1 Whole Inactivated Virus Vaccine at Elevated Storage Temperatures

Felix Geeraedts, Vinay Saluja, Wouter ter Veer, +5

The AAPS Journal

Evaluation of monophosphoryl lipid A as adjuvant for pulmonary delivered influenza vaccine

Harshad P. Patil, Senthil Murugappan, Wouter ter Veer, +6

Journal of Controlled Release

VaccinationMucosal VaccinationVaccine DevelopmentImmunologyInfluenza Vaccine +4

Physical and immunogenic stability of spray freeze-dried influenza vaccine powder for pulmonary delivery: Comparison of inulin, dextran, or a mixture of dextran and trehalose as protectants

Senthil Murugappan, Harshad P. Patil, Gaurav Kanojia, +5

European Journal of Pharmaceutics and Biopharmaceutics

VaccinationMucosal VaccinationCross-protectionVaccine DevelopmentAllergy +7

Intracytoplasmic Trapping of Influenza Virus by a Lipophilic Derivative of Aglycoristocetin

Evelien Vanderlinden, Els Vanstreels, Eline Boons, +8

Journal of Virology

Influenza antigen-sparing by immune stimulation with Gram-positive enhancer matrix (GEM) particles

Vinay Saluja, M.R. Visser, Wouter ter Veer, +5

Vaccine

VaccinationMucosal VaccinationCross-protectionHumoral ResponseImmunology +8

VIROSOMES IN VACCINE DEVELOPMENT: INDUCTION OF CYTOTOXIC T LYMPHOCYTE ACTIVITY WITH VIROSOME-ENCAPSULATED PROTEIN ANTIGENS

Laura Bungener, Jacqueline Idema, Wouter ter Veer, +3

Journal of Liposome Research

Mhc ClassImmunologyViral PathogenesisImmunodominanceAntigen Processing +14

Incorporation of LpxL1, a detoxified lipopolysaccharide adjuvant, in influenza H5N1 virosomes increases vaccine immunogenicity

Jutte J.C. de Vries, Laura Bungener, Wouter ter Veer, +4

Vaccine

VaccinationVaccine DevelopmentAllergyVaccine ImmunogenicityImmunology +7

Preclinical evaluation of the saponin derivative GPI-0100 as an immunostimulating and dose-sparing adjuvant for pandemic influenza vaccines

Heng Liu, Laura Bungener, Wouter ter Veer, +3

Vaccine